Investing in Elanco Animal Health Incorporated (ELAN)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)13.55-6
Intrinsic value (DCF)13.18-8
Graham-Dodd Method0.00-100
Graham Formula0.30-98

Company description

ELAN Corporation Plc (ELAN) is a biotechnology company that specializes in the research, development, and commercialization of innovative therapies for neurological and autoimmune diseases. Headquartered in Dublin, Ireland, ELAN was founded in 1969 and has since become a global leader in the biopharmaceutical industry. The company's product portfolio includes treatments for multiple sclerosis, Alzheimer's disease, and Parkinson's disease, among others. Additionally, ELAN has a strong pipeline of potential new treatments for various indications in different stages of development. The company has a partnership with leading pharmaceutical companies such as Biogen Idec, that aids in the development and commercialization of its products. With a focus on delivering breakthrough therapies to patients in need, ELAN continues to drive success and growth in the ever-evolving world of biotechnology.